These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12188919)

  • 1. Integrins as novel drug targets for overcoming innate drug resistance.
    Damiano JS
    Curr Cancer Drug Targets; 2002 Mar; 2(1):37-43. PubMed ID: 12188919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation.
    Damiano JS; Hazlehurst LA; Dalton WS
    Leukemia; 2001 Aug; 15(8):1232-9. PubMed ID: 11480565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin-mediated drug resistance in multiple myeloma.
    Damiano JS; Dalton WS
    Leuk Lymphoma; 2000 Jun; 38(1-2):71-81. PubMed ID: 10811449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Integrins, cell response to anti-tumor agents and chemoresistance].
    Maubant S; Staedel C; Gauduchon P
    Bull Cancer; 2002 Nov; 89(11):923-34. PubMed ID: 12495880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR).
    Hazlehurst LA; Damiano JS; Buyuksal I; Pledger WJ; Dalton WS
    Oncogene; 2000 Sep; 19(38):4319-27. PubMed ID: 10980607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death.
    Hazlehurst LA; Landowski TH; Dalton WS
    Oncogene; 2003 Oct; 22(47):7396-402. PubMed ID: 14576847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signalling via integrins: implications for cell survival and anticancer strategies.
    Hehlgans S; Haase M; Cordes N
    Biochim Biophys Acta; 2007 Jan; 1775(1):163-80. PubMed ID: 17084981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research advance on role of tumor microenvironment in mediating acquired drug resistance].
    Ma XL; Xing H; Ma D
    Ai Zheng; 2007 Aug; 26(8):923-6. PubMed ID: 17697561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin-mediated cell-matrix interactions for prosurvival and antiapoptotic signaling after genotoxic injury.
    Cordes N
    Cancer Lett; 2006 Oct; 242(1):11-9. PubMed ID: 16448744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma.
    Noborio-Hatano K; Kikuchi J; Takatoku M; Shimizu R; Wada T; Ueda M; Nobuyoshi M; Oh I; Sato K; Suzuki T; Ozaki K; Mori M; Nagai T; Muroi K; Kano Y; Furukawa Y; Ozawa K
    Oncogene; 2009 Jan; 28(2):231-42. PubMed ID: 18850009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Targeting of Integrins and Integrin-Associated Signaling Networks in Radiation Oncology.
    Vehlow A; Storch K; Matzke D; Cordes N
    Recent Results Cancer Res; 2016; 198():89-106. PubMed ID: 27318682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrins and extracellular matrix: a novel mechanism of multidrug resistance.
    Elliott T; Sethi T
    Expert Rev Anticancer Ther; 2002 Aug; 2(4):449-59. PubMed ID: 12647988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
    Hartmann TN; Burger JA; Glodek A; Fujii N; Burger M
    Oncogene; 2005 Jun; 24(27):4462-71. PubMed ID: 15806155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor microenvironment: focus on myeloma.
    Dalton WS
    Cancer Treat Rev; 2003 May; 29 Suppl 1():11-9. PubMed ID: 12738239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells.
    Nakagawa Y; Nakayama H; Nagata M; Yoshida R; Kawahara K; Hirosue A; Tanaka T; Yuno A; Matsuoka Y; Kojima T; Yoshitake Y; Hiraki A; Shinohara M
    Int J Oncol; 2014 Apr; 44(4):1376-84. PubMed ID: 24452447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrins in cell adhesion and signaling.
    Akiyama SK
    Hum Cell; 1996 Sep; 9(3):181-6. PubMed ID: 9183647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor microenvironment as a determinant of drug response and resistance.
    Dalton WS
    Drug Resist Updat; 1999 Oct; 2(5):285-288. PubMed ID: 11504502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis.
    Rüegg C; Dormond O; Mariotti A
    Biochim Biophys Acta; 2004 Mar; 1654(1):51-67. PubMed ID: 14984767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular matrix regulation of drug resistance in small-cell lung cancer.
    Hodkinson PS; Mackinnon AC; Sethi T
    Int J Radiat Biol; 2007; 83(11-12):733-41. PubMed ID: 17852559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.